Updated:
Leavitt Equity Partners
Leavitt Equity Partners is a private equity firm focused on the healthcare sector.
Leavitt Equity Partners
Leavitt Equity Partners is a private equity firm focused on the healthcare sector. It invests in healthcare businesses, providing resources and support to enhance their value. The firm's investments include healthcare provider systems, health insurers, service providers, IT companies, and pharmaceutical companies.
General information
Firm type
Private Equity
Year founded
2013
AUM
$50M - $150M (Altss estimate)
Location
Region
North America
Country
United States
City
Salt Lake City
Corporate office
Salt Lake City, UT, United States
Principals
David J. Leavitt
Founder & Managing Partner
Taylor Leavitt
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Leavitt Equity Partners?
David J. Leavitt, the firm's Founder and Managing Partner, leads investment decisions. His brother Taylor Leavitt serves as Partner and is involved in deal execution and portfolio management. The tight partnership structure means decisions are made by this core group rather than through a broad committee.
How does Leavitt Equity Partners source proprietary deal flow?
The firm sources through the Leavitt family's extensive healthcare policy and provider networks. Michael Leavitt's tenure as HHS Secretary and his ongoing work through Leavitt Partners provided relationships with hospital systems, health plans, and regulatory bodies. LEP often sees deals where the operating company founder is an industry veteran within the Leavitt network.
Is Leavitt Equity Partners related to Leavitt Partners, the consulting firm?
Yes, they share a family connection but are legally distinct entities. Leavitt Partners was founded by Michael O. Leavitt and focused on healthcare advisory and intelligence. It was acquired by Health Management Associates (HMA) in 2021. Leavitt Equity Partners is run by his son David and operates as an independent private equity firm.
What investment stages does Leavitt Equity Partners typically target?
The firm targets growth equity and buyout opportunities in the lower middle market. They seek companies with established revenue and operating history, usually post-revenue commercial-stage businesses, rather than seed or early-stage startups. The emphasis is on accelerating growth through operational and regulatory navigation rather than product-market-fit risk.
What is Leavitt Equity Partners' known posture on co-investments?
LEP typically leads or co-leads rounds in its target companies and has collaborated with other healthcare-focused funds. Given its lean team and relationship-driven model, the firm often syndicates with other specialist healthcare investors who bring complementary operating or distribution capabilities.
Which sectors does Leavitt Equity Partners explicitly avoid?
The firm avoids therapeutics, biotech, and medical device hardware — areas requiring FDA-intensive scientific risk. They focus on healthcare services, health IT, and digital health where regulatory and business-model expertise is the primary value driver rather than clinical trial outcomes.
Where does the Leavitt family wealth originate?
The wealth is not from a single liquidity event but from multi-generational professional and political careers. Michael Leavitt built Leavitt Partners into a premier healthcare advisory firm, and David Leavitt previously worked in healthcare investment banking and private equity before raising outside capital for LEP.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: